Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 1316
Selected: 0
NCT IDTitle
NCT02204085A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT00428233Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation
NCT03227432An Exploratory Study to Evaluate the Combination of Elotuzumab and Nivolumab With and Without Pomalidomide in Relapsed Refractory Multiple Myeloma
NCT00308178Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer
NCT05800366A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma
NCT00165334Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer
NCT00588107A Web Site and Print Materials Intervention for Smoking Intervention for Childhood and Young Adult Cancer Survivors
NCT00869999Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma
NCT01340300Exercise and Metformin in Colorectal and Breast Cancer Survivors
NCT07601100Isatuximab, Iberdomide, Bortezomib, Dexamethasone in Transplant Ineligible/Deferred Newly Diagnosed Myeloma
NCT02950987Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes
NCT01078974Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia
NCT06831552Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
NCT04141449A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation
NCT02207504Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer
NCT03244826Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation
NCT05524025The SPOT-HPV Study
NCT04323774Intervention For Adolescents and Young Adults (AYAs) With Cancer Risk Syndromes
NCT00146601Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer
NCT00136422Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia
NCT00165412Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease
NCT03020030Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
NCT02747888Hereditary Risk Factors for Thyroid Cancer
NCT03152318A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
NCT03716180DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC
NCT01661868Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer
NCT06623097Exercise and Nutrition for Older Cancer Survivors and Their Support Person: The Vitality Study
NCT04634435Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients
NCT05383196Onvansertib + Paclitaxel In TNBC
NCT03865589Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome
NCT03735446Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial
NCT01853345iCAT for Recurrent/Refractory/HR Solid Tumors
NCT00545792Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers
NCT04883671Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial
NCT00004081Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer
NCT03032107A Study Of Pembrolizumab In Combination With Trastuzumab-DM1
NCT03141671Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)
NCT02123966An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease
NCT01965353A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple Myeloma
NCT04851522Dilute Bleach Compresses for Radiation Dermatitis
NCT00134654Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer
NCT02873962A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib
NCT01750762Lenalidomide After Allo Transplant
NCT00483223Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response
NCT06335745PediCARE Health Equity Intervention in High-Risk Neuroblastoma
NCT00458653Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma
NCT02999477A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer
NCT01579552Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer
NCT00925652Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer
NCT00153933Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma